A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

BACKGROUND: Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor subsets most amenable to angiogenesis modulation are lacking. METHODS: We prof...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pentheroudakis, George, Kotoula, Vassiliki, Fountzilas, Elena, Kouvatseas, George, Basdanis, George, Xanthakis, Ioannis, Makatsoris, Thomas, Charalambous, Elpida, Papamichael, Demetris, Samantas, Epaminontas, Papakostas, Pavlos, Bafaloukos, Dimitrios, Razis, Evangelia, Christodoulou, Christos, Varthalitis, Ioannis, Pavlidis, Nicholas, Fountzilas, George
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933361/
https://ncbi.nlm.nih.gov/pubmed/24555920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-111
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados